Incyte shares rose Thursday after the drugmaker named Bill Meury its new CEO, effective immediately, to replace the retiring Hervé Hoppenot. https://t.co/COaakpC1HT ...

Stock Performance - Novo Nordisk's U.S-listed shares experienced a rise [1] Market Activity - An activist investor is reportedly building a stake in Novo Nordisk, the maker of Ozempic [1]